<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711107/" ref="ordinalpos=3640&amp;ncbi_uid=5102705&amp;link_uid=PMC3711107" image-link="/pmc/articles/PMC3711107/figure/F7/" class="imagepopup">Figure 7. The Effect of IGF-1R siRNA on mTOR <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> is Reversed by AICAR.  From: CROSSTALK BETWEEN THE AMP-ACTIVATED KINASE AND INSULIN <span class="highlight" style="background-color:">SIGNALING</span> PATHWAYS RESCUES MURINE BLASTOCYST CELLS FROM INSULIN RESISTANCE. </a></div><br /><div class="p4l_captionBody">TS IGF-1R knockdown cells were incubated 2h with AICAR (250μM). Lysates were harvested and analyzed by Western blotting using antibodies specific for (A) p-mTOR, (B) p-70S6K, and (C) p-riboS6K. The p-mTOR Western blot was quantitated using densitometry and NIH image software, and normalized to β-Actin in the corresponding graph.</div></div>